Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Victor G VogelThe University of Pittsburgh Cancer Institute, Magee-Womens Hospital, Pittsburgh, PA, USAAbstract: Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolis...

Full description

Bibliographic Details
Main Author: Victor G Vogel
Format: Article
Language:English
Published: Dove Medical Press 2008-12-01
Series:Clinical Interventions in Aging
Subjects:
raloxifene
osteoporosis
breast cancer risk reduction
Online Access:https://www.dovepress.com/managing-the-risk-of-invasive-breast-cancer-in-women-at-risk-for-breas-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/managing-the-risk-of-invasive-breast-cancer-in-women-at-risk-for-breas-peer-reviewed-article-CIA

Similar Items